Podcasts about richard doll

Bilginin korkunç bir hızda aktığı zamanlardayız. Teknoloji ve sosyal medyanın gelişimi sayesinde bilgiye ulaşmak, hiç bu kadar kolay olmamıştı. Fakat iletişimin bu kadar kolay olmasının bazı olumsuz etkileri de var elbette. Örneğin post-truth, yani gerçek ötesi kavramı... Artık bir bilginin doğru veya yanlış olduğunu anlamak eskisi kadar kolay değil. Hatta yalan olduğunu içten içe bildiğimiz bazı bilgileri büyütebiliyor, o duvara bir tuğla da biz koyabiliyoruz. 111 Hz'in bu bölümünde post-truth çağında doğru bilgiye nasıl ulaşabileceğimiz üzerine düşünüyoruz. Yalan haberlere ya da bilgilere neden inandığımızı ve bunlara karşı nasıl önlemler alabileceğimizi araştırıyoruz.Sunan: Barış ÖzcanHazırlayan: Özgür YılgürSes Tasarım ve Kurgu: Metin BozkurtYapımcı: Podbee Media------- Podbee Sunar -------Bu podcast, getirfinans hakkında reklam içerir.getirfinans iyi faizi vade beklemeden günlük kazandırır. Kredi faiz oranı düşüktür. Aidatsız kredi kartı sunar. Para transferinden ücret almaz. Sen de getirfinanslı ol.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

No mês dedicado ao Aleitamento Materno no Brasil, trazemos um episódio mais do que especial para vocês:Cesar Victora é Professor Emérito de Epidemiologia na Universidade Federal de Pelotas, onde coordena o Centro Internacional de Equidade em Saúde. Ocupou também cargos honorários nas Universidades de Harvard, Oxford e Johns Hopkins. Desde a década de 1970, tem atuado nas áreas de saúde materno-infantil, cortes de nascimento, desigualdades em saúde e avaliação de impacto de programas de larga escala. Suas pesquisas sobre aleitamento materno, realizadas nos anos 1980, influenciaram políticas mundiais de saúde que foram adotadas por mais de 140 países. Possui mais de 800 artigos publicados, com um índice H de 106 (mais de 55.000 citações) conforme o Web of Science, instituição que de 2018 a 2022 o incluiu na lista dos 1% de cientistas mais citados no mundo. Em 2017, recebeu o Prêmio Gairdner de Saúde Global, no Canadá, e em 2021 o Prêmio Richard Doll de Epidemiologia e em 2023 o Prêmio Almirante Álvaro Alberto do CNPq e Marinha do Brasil. Em 2018, recebeu o título de Doutor Honoris Causa concedido pelaUniversidade Federal do Rio Grande do Sul (UFRGS).Paulo Neves é nutricionista com doutorado em Ciências da Nutrição em Saúde Pública pela Universidade de São Paulo. Atualmente é pesquisador do Centre for Global Child Health, The Hospital for Sick Children, Toronto, Canadá. É membro do 2023 Lancet Breastfeeding Series Group.Não esqueça: você pode ter acesso aos artigos do nosso Journal Club no nosso site: https://www.the-incubator.org/podcast-1 Se estiver gostando do nosso Podcast, por favor deixe sua avaliação no seu aplicativo favorito e compartilhe com seus colegas. O nosso objetivo é democratizar a informação. Se quiser entrar em contato, nos mandar sugestões, comentários, críticas e elogios, manda um e-mail pra gente: incubadora@the-incubator.org

Derek Hockaday interviews Martin Vessey, Emeritus Professor of Public Health, 4 June 2014 Topics discussed include: (00:00:15) how MV came to Oxford; (00:01:36) John Honour; (00:03:46) choosing to focus on epidemiology and statistics, learning about statistics and computing post medical qualification and return to clinical house appointments; (00:07:28) meeting Richard Doll; (00:10:14) comparing Oxford and London computing facilities; (00.11:39) MD thesis, United States trip and return to Oxford, (00:14:39) work under direction of Richard Doll at Medical Research Council statistical research unit and effect on direction of career; (00:18:26) MRC and World Health Organisation; (00:19:49) fertilisation and contraceptive work; (00:23:42) studies relating to the etiology of cervical cancer; (00:26:58) research into menopause and investigation of hormone replacement; (00:31:22) differences in different generations of contraceptive pills; (00:36:34) social and community medicine in relation to epidemiology; (00:42:02) interactions with and teaching medical students; (00:48:57) attending medical and surgical grand rounds; (00:50:17) research, papers and breast cancer screening; (00:55:51) Royal Commission on Environmental Pollution; (00:58:50) Rosemary Rue; (01:02:04) travelling for conferences; (01:04:10) supervising DPhil students; (01:09:20) final thoughts on career; (01:11:53) women in epidemiology and medicine.

Derek Hockaday interviews Mike Dunnill, researcher, pathologist and former Director of Clinical Studies,10 February 2012. Topics discussed include: (00:00:10) first coming to Oxford from Bristol in 1956, Department of Pathology facilities; (00:04:00) becoming interested in medical education, George Pickering's committee for Medical School at Nottingham; (00:05:18) becoming Director of Clinical Studies in 1967; (00:06:15) report outlining changes to Honours schools coinciding with the Royal Commission on Medical Education,1969; (00:11:27) lunchtime post-mortem demonstrations; (00:15:21) the [Richard] Doll committee; (00:19:46) graduate assistants work in 1950s in Oxford; (00:21:10) staff on the Pathology course; (00:25:16) the Nuffield Committee; (00:26:38) increasing student numbers for clinical school; (00:28:10) George Pickering.

Interview with Trevor Hughes, neuropathologist and fellow of Green Templeton College, conducted by Derek Hockaday, 2015. Topics discussed included: (00:00:17) Hughes coming to Oxford from Stoke Mandeville in 1957; (00:05:12) how Stoke Mandeville and Oxford hospitals compared to each other, distinctions between Oxford hospitals; (00:07:18) changes in Oxford hospitals as a result of the creation of NHS in 1948, comparing Oxford to Manchester in the 1940s; (00:10:04) moving to neuropathology over haematology; (00:14:38) John Spalding; (00:18:12) neuropathology during the the Second World War, memories of staff colleagues including Peter Daniel and Sabrina Strich, more on John Spalding; (00:33:05) Honor Smith; (00:40:16) change of techniques in neuropathology over time, working in field; (00:44:30) balancing consultancy, teaching and tutor for post-graduate medicine in Oxford; (00:48:18) neurosurgeons including Joe Pennybacker, Hugh Cairns and Walpole Lewin, other Nuffield Professors; (00:59:10) committees and the university including the Nuffield Committee for Medical Research and the Clinical Medicine Board; (01:08:13) working with Richard Doll; (01:18:56) researching of the spinal cord, publication; (01:21:35) neuropathology and the John Radcliffe Hospital. Note the following sections of audio are redacted: 00:16:38-00:17:01; 00:18:55-00:19:07; 00:26:19-00:29:14; 00:31:37-00:31:47; 00:56:45-56:59; 01:11-01:13:21; 01:14:37-01:15:22; 01:22:17-01:24:00.

Peggy Frith interviews Derek Hockaday, 24 Sep 2020 Topics discussed include: (00:00:22) context of interviewing Derek Hockaday, thoughts on the recollecting oxford medicine interviews in general; (00:01:40) getting into medicine, first contact with the Radcliffe Infirmary as a patient in 1946, school days; (00:03:46) time at Brasenose college, Oxford in 1947; (00:05:30) George Gordon and increasing terms tutored in physiology; (00:06:55) research in physiology; (00:07:55) being drawn to clinical medicine; (00:08:42) BSc research work; (00:11:10) clinical training in the Middlesex Hospital; (00:13:31) anecdotes about clinical student visits; (00:15:15) medical finals; (00:16:10) Wheatley Military Hospital; (00:17:59) discussing Hugh Cairns and Cairns hospital for head injuries; (00:19:48) George Pickering, Ian Bush and chemical investigations into psychiatric patients; (00:24:00) angiography patients at Wheatley, angiography pre scanning; (00:26:59) George Pickering; (00:28:22) Cambridge pre-clinical students coming to train clinically at Oxford; (00:29:38) year in Boston, Massachusetts endocrine unit at the Mass. General Hospital; (00:35:20) returning from America to Oxford, becoming a consultant; (00:39:37) the Oxford Diabetic Clinic, introduction of dialysis to Oxford; (00:43:24) wards and firms looking after patients; (00:44:13) hutted wards; (00:45:06) teaching and lecturing of clinical students; (00:45:50) medical tutor 1980 at Brasenose; (00:48:09) training diabetologists including George Alberti; (00:51:13) Sheffield speciality in Renal medicine, influence of Ranjan Yajnik on diabetic medicine in India; (00:52:57) figures involved in Oxford research in diabetes; (00:54:43) diabetic coma treatments research trials; (01.01:33) contact bedside testing; (01.02:33) inception of, and effect of Sheikh Rashid Diabetes Unit, Oxford; (01:10:16) the fifth principle of physiology; (01:11:10) randomised trial on diabetic treatments and Richard Doll; (01:12:10) side effect of alcohol flushing; (01:15:04) medical administration; (01.23:25) sport; (01:28:14) final thoughts including clinical appointment times, praising nursing profession and first ward round as consultant. Note the following sections are redacted: 00:33:21-00:33:43; 00:40:35-00:41:54; 001:12:47-01:12:56.

The usual history says that the link between smoking and lung cancer was first shown by the British epidemiologist Richard Doll in 1952. But that's not quite true. The first people to show this link were... actually bad people. Will tells Rod and special guest CjJosh the story of the Nazi war on tobacco! The Wholesome Show is Dr Will Grant and Dr Rod Lamberts - joined today by CJJosh! Proudly produced by G'day Studios, and brought to you by The Australian National Centre for the Public Awareness of Science!

When Sir Richard Peto began work with the late Richard Doll fifty years ago, the UK had the worst death rates from smoking in the world. Smoking was the cause of more than half of all premature deaths of British men. The fact that this country now boasts the biggest decrease in tobacco-linked mortality is in no doubt partly due to Doll and Peto's thirty year collaboration. Professor of Medical Statistics and Epidemiology at the University of Oxford and until last year co-director of the Clinical Trial Service Unit with Professor Sir Rory Collins, Richard Peto pioneered "big data", setting up enormous randomised clinical trials and then, in a novel approach, combining results in what became known as meta-analyses, amassing unequivocal evidence about how early death could be avoided. He showed how asprin could prevent heart attacks and how the oestrogen-blocking drug tamoxifen really did affect survival rates for breast cancer patients. Results on paper saves lives in the real world, he says, and he's famous for catchphrases like: "death in old age is inevitable, but death before old age is not" and "you can avoid more deaths by a moderate reduction of a big cause, than by a big reduction in a small cause" as well as "take the big numbers seriously". One of the world's leading epidemiologists, Richard Peto's landmark study with Alan Lopez at the World Health Organisation predicted that a billion people would die from diseases associated with tobacco this century, compared to a hundred million killed by tobacco in the 20th century. The chilling message galvanised governments around the world to adopt anti-smoking policies. And Professor Peto's studies about smoking cessation ("smoking kills, stopping works") provided the public health evidence needed to encourage smokers that, however long they had smoked for, it was always worth quitting.

This month we have some more feedback from our listeners (2.20) Carl says it's time to start smoking cessation (or stop the reduction in funding for smoking reduction) (11.40) and marvels at how pretty Richard Doll's seminal smoking paper is. It's gloves off for infection control (22.20) Andrew George, a non-executive director of the Health Research Authority joins us to talk about their consultation on research transparency, and explains how you can get involved (27.04) And we talk about a new tool for rating the transparency of pharma companies (37.40) Reading list: Impact of the WHO Framework Convention on Tobacco Control on global cigarette consumption https://www.bmj.com/content/365/bmj.l2287 Sixty seconds on . . . gloves off https://www.bmj.com/content/366/bmj.l4498 HRA transparency consultation https://www.hra.nhs.uk/about-us/consultations/make-it-public/our-vision-research-transparency/ Sharing of clinical trial data and results reporting practices among large pharmaceutical companies https://www.bmj.com/content/366/bmj.l4217

This month we have some more feedback from our listeners (2.20) Carl says it's time to start smoking cessation (or stop the reduction in funding for smoking reduction) (11.40) and marvels at how pretty Richard Doll's seminal smoking paper is. It's gloves off for infection control (22.20) Andrew George, a non-executive director of the Health Research Authority joins us to talk about their consultation on research transparency, and explains how you can get involved (27.04) And we talk about a new tool for rating the transparency of pharma companies (37.40) Reading list: Impact of the WHO Framework Convention on Tobacco Control on global cigarette consumption https://www.bmj.com/content/365/bmj.l2287 Sixty seconds on . . . gloves off https://www.bmj.com/content/366/bmj.l4498 HRA transparency consultation https://www.hra.nhs.uk/about-us/consultations/make-it-public/our-vision-research-transparency/ Sharing of clinical trial data and results reporting practices among large pharmaceutical companies https://www.bmj.com/content/366/bmj.l4217

Can we ever know what causes a chronic disease? In this episode, I’m joined again by Dr. Shoshana Herzig to finish a three-part miniseries on Bradford Hill and Doll’s attempts to prove that smoking caused lung cancer. We’ll talk about the first prospective cohort trial in history, 1960s “Fake News” from tobacco companies, public spats with the most famous statistician of the 20th century, and the development of the Bradford Hill Criteria, a guideline, however imperfect, that gives doctors a blueprint to finally figure out what causes diseases. Sources: Crofton J, The MRC randomized trial of streptomycin and its legacy: a view from the clinical front line. J R Soc Med. 2006 Oct; 99(10): 531–534. Daniels M and Bradford Hill A, Chemotherapy of Pulmonary Tuberculosis in Young Adults, Br Med J. 1952 May 31; 1(4769): 1162–1168. Dangers of Cigarette-smoking. Brit Med J 1, 1518 (1957). Doll, R. & Hill, B. A. Lung Cancer and Other Causes of Death in Relation to Smoking. Brit Med J 2, 1071 (1956). Doll, R. & Hill, B. A. Smoking and Carcinoma of the Lung. Brit Med J 2, 739 (1950). Hill, A. The Environment and Disease: Association or Causation? J Roy Soc Med 58, 295–300 (1965). HOFFMAN, F. L. CANCER AND SMOKING HABITS. Ann Surg 93, 50–67 (1931). Keating C, Smoking Kills: The Revolutionary Life of Richard Doll. 2009. Morabia, A. Quality, originality, and significance of the 1939 “Tobacco consumption and lung carcinoma” article by Mueller, including translation of a section of the paper. Prev Med 55, 171–177 (2012). Ochsner, A. & bakey. Primary pulmonary malignancy: treatment by total pneumonectomy; analysis of 79 collected cases and presentation of 7 personal cases. Ochsner J 1, 109–25 (1999). Ochsner, A. My first recognition of the relationship of smoking and lung cancer. Prev Med 2, 611–614 (1973). Parascandola, M. Two approaches to etiology: the debate over smoking and lung cancer in the 1950s. Endeavour 28, 81–86 (2004). Phillips, C. V. & Goodman, K. J. The missed lessons of Sir Austin Bradford Hill. Epidemiologic Perspectives Innovations 1, 1–5 (2004). Proctor, R. Angel H Roffo: the forgotten father of experimental tobacco carcinogenesis. B World Health Organ 84, 494–495 (2006). Wynder, E. RE: “WHEN GENIUS ERRS: R. A. FISHER AND THE LUNG CANCER CONTROVERSY”. Am J Epidemiol 134, 1467–9 (1991).

Does smoking cause lung cancer? How could you ever know? The second in a three-part series on causality, I’m joined by Dr. Shoshana Herzig to discuss how Austin Bradford Hill and Richard Doll set out to try and answer this question -- and along the way revolutionized the way we think about what causes disease. In this episode, we’ll talk about the first double-blinded randomized controlled trial, the long shadow of tuberculosis, and why epidemiology is beautiful. Plus, a brand new #AdamAnswers about chest compressions! Please support Bedside Rounds by filling out the listener demographic survey: https://survey.libsyn.com/bedsiderounds Sources: Bost TC. Cardiac arrest during anaesthesia and surgical operations. Am J Surg 1952;83: 135-4 Council, T. Tobacco Smoking and Lung Cancer. Brit Med J 1, 1523 (1957). Crofton J, The MRC randomized trial of streptomycin and its legacy: a view from the clinical front line. J R Soc Med. 2006 Oct; 99(10): 531–534. Daniels M and Bradford Hill A, Chemotherapy of Pulmonary Tuberculosis in Young Adults, Br Med J. 1952 May 31; 1(4769): 1162–1168. Dangers of Cigarette-smoking. Brit Med J 1, 1518 (1957). Doll, R. & Hill, B. A. Lung Cancer and Other Causes of Death in Relation to Smoking. Brit Med J 2, 1071 (1956). Doll, R. & Hill, B. A. Smoking and Carcinoma of the Lung. Brit Med J 2, 739 (1950). Hill, A. The Environment and Disease: Association or Causation? J Roy Soc Med 58, 295–300 (1965). HOFFMAN, F. L. CANCER AND SMOKING HABITS. Ann Surg 93, 50–67 (1931). Hurt R, Modern cardiopulmonary resuscitation—not so new after all. J R Soc Med. 2005 Jul; 98(7): 327–331. Keating C, Smoking Kills: The Revolutionary Life of Richard Doll. 2009. Keith A, Three Hunterian Lectures ON THE MECHANISM UNDERLYING THE VARIOUS METHODS OF ARTIFICIAL RESPIRATION PRACTISED SINCE THE FOUNDATION OF THE ROYAL HUMANE SOCIETY IN 1774. (1909). The Lancet, 173(4464), 825–828. Kouwenhoven WB et al, Closed-chest cardiac massage, JAMA, JAMA. 1960;173(10):1064-1067. Morabia, A. Quality, originality, and significance of the 1939 “Tobacco consumption and lung carcinoma” article by Mueller, including translation of a section of the paper. Prev Med 55, 171–177 (2012). Ochsner, A. & bakey. Primary pulmonary malignancy: treatment by total pneumonectomy; analysis of 79 collected cases and presentation of 7 personal cases. Ochsner J 1, 109–25 (1999). Ochsner, A. My first recognition of the relationship of smoking and lung cancer. Prev Med 2, 611–614 (1973). Parascandola, M. Two approaches to etiology: the debate over smoking and lung cancer in the 1950s. Endeavour 28, 81–86 (2004). Phillips, C. V. & Goodman, K. J. The missed lessons of Sir Austin Bradford Hill. Epidemiologic Perspectives Innovations 1, 1–5 (2004). Proctor, R. Angel H Roffo: the forgotten father of experimental tobacco carcinogenesis. B World Health Organ 84, 494–495 (2006). Wynder, E. RE: “WHEN GENIUS ERRS: R. A. FISHER AND THE LUNG CANCER CONTROVERSY”. Am J Epidemiol 134, 1467–9 (1991).

When Sir Richard Peto began work with the late Richard Doll fifty years ago, the UK had the worst death rates from smoking in the world. Smoking was the cause of more than half of all premature deaths of British men. The fact that this country now boasts the biggest decrease in tobacco-linked mortality is in no doubt partly due to Doll and Peto's thirty year collaboration. Professor of Medical Statistics and Epidemiology at the University of Oxford and until last year co-director of the Clinical Trial Service Unit with Professor Sir Rory Collins, Richard Peto pioneered "big data", setting up enormous randomised clinical trials and then, in a novel approach, combining results in what became known as meta-analyses, amassing unequivocal evidence about how early death could be avoided. He showed how asprin could prevent heart attacks and how the oestrogen-blocking drug tamoxifen really did affect survival rates for breast cancer patients. Results on paper saves lives in the real world, he says, and he's famous for catchphrases like: "death in old age is inevitable, but death before old age is not" and "you can avoid more deaths by a moderate reduction of a big cause, than by a big reduction in a small cause" as well as "take the big numbers seriously". One of the world's leading epidemiologists, Richard Peto's landmark study with Alan Lopez at the World Health Organisation predicted that a billion people would die from diseases associated with tobacco this century, compared to a hundred million killed by tobacco in the 20th century. The chilling message galvanised governments around the world to adopt anti-smoking policies. And Professor Peto's studies about smoking cessation ("smoking kills, stopping works") provided the public health evidence needed to encourage smokers that, however long they had smoked for, it was always worth quitting. Producer: Fiona Hill

The New Elizabethans: Richard Doll. To mark the Diamond Jubilee, James Naughtie examines the lives of the men and women who have given the second Elizabethan age its character. 60 years ago, 80% of British adults were smokers. The fact that this figure is now nearer 20% is largely down to the work of epidemiologist Sir Richard Doll, who in 1954 published the first scientific research paper proving the link between cigarette smoking and lung cancer. His dogged and determined research finally led governments world wide to challenge the tobacco industry and to initiate a whole new era of public health management. Sir Richard was to make many more contributions to epidemiology, including work on the health effects of asbestos and the contraceptive pill. He gave up smoking himself while doing the initial research in the 50's, which may have contributed to the fact that he lived to 92, long enough to witness the legislation to outlaw smoking in public places in Britain. The New Elizabethans have been chosen by a panel of leading historians, chaired by Lord (Tony) Hall, Chief Executive of London's Royal Opera House. The panellists were Dominic Sandbrook, Bamber Gascoigne, Sally Alexander, Jonathan Agar, Maria Misra and Sir Max Hastings. They were asked to choose: "Men and women whose actions during the reign of Elizabeth II have had a significant impact on lives in these islands and/or given the age its character, for better or worse." Producer: Mike Tighe.

From the 2010 Alumni Weekend. Conrad Keating, biographer of Richard Doll, gives a talk on the difficulty scientists have at getting people to believe their results, as Richard Doll had when he published his findings on the dangers of smoking.

From the 2010 Alumni Weekend. Conrad Keating, biographer of Richard Doll, gives a talk on the difficulty scientists have at getting people to believe their results, as Richard Doll had when he published his findings on the dangers of smoking.

Conrad Keating, biographer of Richard Doll, lectures on the life of the cancer epidemiologist and lifelong socialist who contributed much to our understanding of the effects of smoking and changed the way we regard smoking and public health.

Sue Lawley's castaway is epidemiologist Professor Sir Richard Doll.Favourite track: Rhapsody in Blue by George Gershwin Book: Oxford Textbook of Medicine by D A Warrell Luxury: A down pillow

Sue Lawley's castaway is epidemiologist Professor Sir Richard Doll. Favourite track: Rhapsody in Blue by George Gershwin Book: Oxford Textbook of Medicine by D A Warrell Luxury: A down pillow